Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-009976)

Filing Details

Accession Number:: 0000899243-20-009976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-02 15:30:39
Reporting Period:: 2020-03-31

Accepted Time:: 2020-04-02 15:30:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724190	P. William Quinn	Sunesis Pharmaceuticals, Inc. 395 Oyster Point Boulevard, Ste. 400 South San Francisco CA 94080	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-31	6,000	$0.65	121,697	No	4	P	Direct
Common Stock	Acquisiton	2019-11-29	6,000	$0.37	127,697	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2020-03-31	360,000	$0.00	360,000	$0.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
360,000		2030-03-31	No	4	A	Direct

Footnotes

Shares acquired under the Issuer's stock purchase plan.
One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months.